Geode Capital Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $15.6M | Buy |
|
|||||
|
2024
Q3 | $4.63M | Sell |
|
|||||
|
2024
Q2 | $4.74M | Buy |
|
|||||
|
2024
Q1 | $4.99M | Buy |
|
|||||
|
2023
Q4 | $5.12M | Buy |
|
|||||
|
2023
Q3 | $3.38M | Buy |
|
|||||
|
2023
Q2 | $2.16M | Buy |
|
|||||
|
2023
Q1 | $1.56M | Buy |
|
|||||
|
2022
Q4 | $2.6M | Buy |
|
|||||
|
2022
Q3 | $1.61M | Buy |
|
|||||
|
2022
Q2 | $677K | Sell |
|
|||||
|
2022
Q1 | $2.25M | Buy |
|
|||||
|
2021
Q4 | $3.34M | Buy |
|
|||||
|
2021
Q3 | $2.75M | Buy |
|
|||||
|
2021
Q2 | $3.77M | Sell |
|
|||||
|
2021
Q1 | $3.85M | Buy |
|
|||||
|
2020
Q4 | $2.33M | Buy |
|
|||||
|
2020
Q3 | $1.68M | Buy |
|